The U.S. National Institutes of Health (NIH) recently supported clinical trials of an experimental malaria vaccine in adults and found that all three tested regimens were safe.
One of the trials enrolled healthy women who anticipated becoming pregnant soon after immunization.
That trial began with drug treatment to remove malaria parasites, followed by three injections spaced over a month of either saline placebo or the investigational vaccine at one of two dosages.
Read More
